Results for this period
First quarter1 January 2026–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Net sales increased as a result of growth in the number of customer establishments, registered workers, and job listings, as well as an increase in the number of medical institutions using the Medical Platform business. The Company also actively pursued growth investments, strengthened its organizational structure, and expanded AI functionality.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–31 March 2026 |
| Net Sales | ¥10,189 million (YoY +25.2%) |
| Operating profit | ¥-67 million |
| Ordinary income | ¥61 million |
| Profit attributable to owners of the parent | ¥-62 million |
| Net income per share | △¥2.08 |
| Equity ratio | End of the current fiscal period 29.9 / End of previous period 35.9 |
| Total assets | ¥43,683 million |
| Net assets | ¥13,057 million |
| Full-year earnings forecast | Net Sales ¥46,400 million (YoY +26.1%) / Operating profit ¥2,950 million (YoY +37.2%) / Ordinary income ¥3,250 million (YoY +47.6%) / Net income ¥1,800 million (YoY +84.5%) |
| Revision to Earnings Forecast | No revision |
| Annual Dividend Forecast | ¥0 → ¥0 |
| Segment revenue | Human Resources Platform Business ¥7,031 million (YoY +27.6%), Healthcare Platform Business ¥2,891 million (YoY +26.3%), Newly developed services ¥266 million (YoY -22.3%) |
| Segment profit | Human Resources Platform Business ¥1,709 million (YoY +28.4%), Healthcare Platform Business ¥-168 million, Newly developed services ¥-163 million |
| Depreciation and amortization | ¥272 million |
| Impairment loss | Not applicable (no material impairment loss related to fixed assets) |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥0 million / Extraordinary loss Loss on sale of fixed assets ¥0 million, Loss on disposal of fixed assets ¥0 million, Loss on step acquisition ¥47 million |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | Newly consolidated: 0 companies; excluded: 0 companies (no material changes during the cumulative first quarter) |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for institutional investors and analysts) |
| Issued Shares at Period-End | 32,738,600 |
| Treasury Shares at Period-End | 2,692,694 |
| Factors Behind Changes in Business Performance | Net sales increased as a result of growth in the number of customer establishments, registered workers, and job listings, as well as an increase in the number of medical institutions using the Medical Platform business. The Company also actively pursued growth investments, strengthened its organizational structure, and expanded AI functionality. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Human Resources Platform business, the number of customer establishments, registered workers, and job listings increased. In the Medical Platform business, adoption of each product remained solid, increasing the number of medical institutions using the services. At the same time, the Company made growth investments in marketing activities, its online training system, strengthening its organizational structure, and expanding AI functionality.